Oral Proteins & Peptides Market to Grow with a CAGR of 9.42% through 2030F

Rising prevalence of chronic diseases, technological advancements, and patient-centric approaches to treatment are expected to drive the Global Oral Proteins & Peptides Market growth in the forecast period, 2026-2030

According to TechSci Research report, “Oral Proteins & Peptides Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030F”, the Global Oral Proteins & Peptides Market stood at USD 1.33 billion in 2024 and is anticipated to grow with a CAGR of 9.42% in the forecast period, 2025-2030. This can be attributed to market expansion beyond therapeutics. The growth potential of oral proteins and peptides extends beyond therapeutic applications. Nutraceuticals and dietary supplements containing these molecules are gaining popularity among health-conscious consumers. These products promise various health benefits, contributing to the diversification of the market.

The oral proteins and peptides are finding new applications beyond their traditional uses. Ongoing research is exploring their potential in treating a broader range of diseases, including rare genetic disorders, autoimmune diseases, and various cancers.

The projected growth of the Oral Proteins And Peptides Market is underpinned by a range of critical factors. These include the increasing prevalence of chronic diseases, a rising global geriatric population, a preference among consumers for oral medications, growing demand for effective treatments and advanced technology, heightened collaboration among pharmaceutical companies, and substantial investments in healthcare infrastructure development.

The expansion of the market is anticipated due to greater consumer purchasing power and heightened research and development efforts within the pharmaceutical sector. Nevertheless, challenges persist, including drug shortages, supply chain issues, and delays in clinical trials for non-COVID-19 therapies, particularly in areas such as oncology and metabolic disorders. The obstacles like high development costs, limited product availability, lack of awareness in emerging economies, and limited oral protein and peptide absorption may impede market growth in the short term.

However, ongoing advancements and expanding research and development activities are expected to address these challenges, paving the way for profitable growth in the oral proteins and peptides market in the years to come.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Oral Proteins & Peptides Market.”

The Global Oral Proteins & Peptides Market is segmented into drug type, application, regional distribution, and company.

Based on its drug type, The fastest-growing segment in the Global Oral Proteins & Peptides Market is anticipated to be Plecanatide, driven by several compelling factors. Plecanatide has demonstrated exceptional efficacy in treating chronic idiopathic constipation (CIC) and irritable bowel syndrome with constipation (IBS-C), addressing a significant unmet medical need. Its oral administration offers a convenient and patient-friendly alternative to traditional injectable therapies, boosting patient compliance. Ongoing research and development, along with potential label expansions for Plecanatide, are expected to strengthen its market presence. As awareness of gastrointestinal disorders grows and healthcare providers increasingly recognize the drug's benefits, Plecanatide's demand is set to surge, making it a key driver of growth in the oral proteins and peptides market.

Based on region, The Asia-Pacific region is the fastest-growing market for oral proteins and peptides due to several key factors. A significant increase in the prevalence of chronic diseases, such as diabetes, gastrointestinal disorders, and cancer, drives the demand for peptide-based treatments. The region's large population and rising healthcare awareness also contribute to market growth. The advancements in oral drug delivery technologies, which enhance the bioavailability and stability of proteins and peptides, are boosting adoption. The shift towards non-invasive treatment options and improved patient compliance with oral formulations are further accelerating market demand. The supportive government initiatives, increased investment in healthcare infrastructure, and growing middle-class income levels in countries like China and India are fueling the expansion of the oral proteins and peptides market in the region.

Major companies operating in Global Oral Proteins & Peptides Market are:

·         AbbVie Inc.

·         Merck & Co Inc

·         Pfizer Inc

·         Novo Nordisk A/S

·         Hoffmann-La Roche Inc

·         Sanofi SA

·         AstraZeneca PLC

·         Bristol-Myers Squibb Co

·         Tarsa Therapeutics Inc

·         Novartis AG

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The global oral proteins & peptides market is poised for a dynamic future characterized by innovation and patient-centric solutions. As personalized medicine, nanotechnology, artificial intelligence, and other trends continue to shape the landscape, patients can look forward to more effective and convenient treatment options. These trends reflect the industry's commitment to improving healthcare outcomes and advancing the field of oral protein and peptide therapies. As the market evolves, it will be important to stay attuned to these trends and developments to harness the full potential of this exciting field”, said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Oral Proteins & Peptides Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Calcitonin, Insulin, Linaclotide, Octreotide, Plecanatide), By Application (Bone Diseases, Diabetes, Gastric & Digestive Disorders, Hormonal Disorders), By Region & Competition, 2020-2030F”, has evaluated the future growth potential of Global Oral Proteins & Peptides Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Oral Proteins & Peptides Market.

Contact

TechSci Research LLC

420 Lexington Avenue, Suite 300,

New York, United States- 10170

Tel: +1-332-258-6602

Email: [email protected]

Website: www.techsciresearch.com